Viewing Study NCT00054405


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-01-08 @ 4:15 PM
Study NCT ID: NCT00054405
Status: TERMINATED
Last Update Posted: 2013-04-09
First Post: 2003-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module